SB 242235 - CAS# 193746-75-7 iglustat Hydrochloride long duration inhibitor of human

long duration inhibitor of human neutrophil elastase (HNE)

It can also cause a reduction in Aβ40 and Aβ42 levels in human primary neuronal cells (IC50 ~115 nM for total Aβ and ~200 nM for Aβ42) and in brain extracts

PubMed Central PMCID: PMC2975629

wetting agents or defoaming agents

Salinomycin hinders the U251 human glioma cell growth in vivo via inhibition of angiogenesis with involvement of AKT and FAK dephosphorylation

SB 242235 - CAS# 193746-75-7 iglustat Hydrochloride long duration inhibitor of humanSB 242235 is a potent and selective p38 MAP kinase inhibitor that may be an effective therapy for cytokine mediated diseases such as autoimmune or inflammatory diseases. SB 242235 demonstrates generally favourable pharmacokinetic properties. Systemic plasma clearance was high in rat, but in the non rodent species SB 242235 demonstrated low to moderate clearance with plasma half lives > 4h. Oral bioavailability in each preclinical species was high. In